Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial

Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial

Abstract Objectives The general objective of this study is to test the hypothesis that administration of convalescent plasma from donors with previous diagnosis of severe COVID-19 pneumonia is safe and associated with a decrease in all-cause in-hospital mortality among hospitalized patients with COV...

Full description

Bibliographic Details
Main Authors: Alonso Soto, Fiorella Krapp, Alex Vargas, Lucía Cabrejos, Enrique Argumanis, Patricia L. García, Karina Altamirano, Martín Montes, Pamela R. Chacón-Uscamaita, Patricia J. García
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Trials
Subjects:
COVID-19
Randomized controlled trial
Protocol
Convalescent plasma
Safety
Adverse reactions
Online Access:https://doi.org/10.1186/s13063-021-05189-6

Internet

https://doi.org/10.1186/s13063-021-05189-6

Similar Items